@article {8675, title = {Generation and characterization of retinal pigment epithelium from patient iPSC line to model oculocutaneous albinism (OCA)1A disease [EyeStem Research Pvt. Ltd. - a C-CAMP Startup and Discovery to Innovation Accelerator, C-CAMP]}, journal = {J. Biosciences }, volume = {49}, year = {2024}, month = {01/2024}, abstract = {

Oculocutaneous albinism (OCA) is characterized by reduced melanin biosynthesis affecting the retina, thus impairing visual function. The disease pathology of OCA is poorly understood at the cellular level due to unavailability of suitable biological model systems. This study aimed to develop a disease-specific\ in vitro\ model for OCA type 1A, the most severe form caused by\ TYR\ (tyrosinase) gene mutations, using retinal pigment epithelium (RPE) differentiated from patient-derived human-induced pluripotent stem cells (hiPSCs). A comparative study between healthy and OCA1A RPE cells revealed that while healthy RPE cells exhibited timely onest of pigmentation during differentiation, OCA1A RPE cells failed to pigment even after an extended culture period. This observation was validated by ultrastructural studies using electron microscopy, hinting at melanosome-specific defects. Immunocytochemistry demonstrated abnormal expression patterns of melanogenesis-specific protein markers in OCA1A RPE cells, indicating reduced or absence of melanin synthesis. Next, a quantitative assay was\ performed to\ confirm the\ absence of melanin production in\ OCA1A RPE cells. Tyrosinase assay showed no activity in OCA1A compared with healthy RPE, suggesting non-functionality of\ TYR, further corroborated by western blot analysis showing complete absence of the protein. Gene expression by RNA sequencing of healthy and OCA1A RPE cells uncovered differential gene expression associated with lens development, visual perception, transmembrane transporter activity, and key signaling pathways. This disease-in-a-dish model of OCA1A provides an excellent platform to understand disease mechanism, identify potential therapeutic targets, and facilitate gene therapy or gene correction.

}, doi = {/doi.org/10.1007/s12038-023-00406-7}, url = {https://link.springer.com/article/10.1007/s12038-023-00406-7}, author = {Janavi Subramani and Niharika Patlolla and Rajani Battu and Taslimarif Saiyed and Rajarshi Pal} }